H0743
Type: B Origin: House Florida Comments: 0

Xylazine

Summary
User Reviews

AI Summary

The Xylazine bill aims to regulate the use of xylazine, a sedative commonly used in veterinary medicine but also misused in human populations as a recreational drug. The bill seeks to classify xylazine as a controlled substance due to its increasing prevalence in opioid overdoses and its potential for abuse. By placing restrictions on the distribution and handling of xylazine, the bill intends to address public health concerns related to its misuse and combat the opioid crisis.

Bill Activity

  • 2023-12-06: Filed

  • 2023-12-19: Referred to Criminal Justice Subcommittee

  • 2023-12-19: Referred to Regulatory Reform & Economic Development Subcommittee

  • 2023-12-19: Referred to Judiciary Committee

  • 2023-12-19: Now in Criminal Justice Subcommittee

  • 2024-01-09: 1st Reading (Original Filed Version)

  • 2024-03-08: Died in Criminal Justice Subcommittee

Overall Bill Rating

0.0
0.0
0.0
0.0
0.0
0.0

Sponsors (1)

Text Versions (1)
Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.